OMNICELL INC (OMCL)
Health Care · Healthcare automation and medication management technology · NASDAQ
Omnicell automates medication management across healthcare settings through storage, dispensing, and intelligence solutions to enable safer, more efficient pharmacy operations.
What OMNICELL INC does
Omnicell is a healthcare technology provider specializing in autonomous medication management solutions for hospitals, health systems, and pharmacy service centers. The company offers storage and dispensing automation platforms powered by an intelligence ecosystem designed to help pharmacists and nurses focus on patient care while reducing medication errors and operational inefficiencies. Its solutions span central pharmacy automation, point-of-care dispensing systems, IV sterile compounding, and pharmacy analytics across acute care and ambulatory settings. The company addresses critical healthcare challenges including workforce shortages, drug diversion liability, and medication management costs through modernized automation and data-driven insights.
Themes: ["Autonomous pharmacy / medication automation","Hospital and health system solutions","Pharmacy workforce efficiency","Medication safety and error reduction","Drug diversion prevention","Healthcare operations optimization","Sterile compounding automation","Analytics and clinical outcomes"]
Fundamentals
- Price$45.59 as of 2026-07-09 close
- Market cap$2.1B as of 2026-07-10
- 1-year return+52.3% as of 2026-07-09 close
- P/E101.74 as of 2026-07-10
- Net margin+1.7% as of 2026-07-10
- Gross margin+43.5% as of 2026-07-10
- ROE+1.6% as of 2026-07-10
- Debt / equity0.13 as of 2026-07-10
- Revenue growth (YoY)+7.9% as of 2026-07-10
- Revenue CAGR (3y)-2.9% SEC XBRL
- Beta0.97 as of 2026-07-10
Key risks (from latest filing)
["Healthcare spending constraints and policy changes (e.g., Medicaid reductions under the One Big Beautiful Bill Act) may impact customer capital spending and timing of solution adoption.","Acute labor shortages in pharmacy and healthcare operations, combined with rising input costs from tariffs, may compress operating margins and delay implementation of automation solutions.","Regulatory requirements and compliance obligations, including Drug Supply Chain Security Act (DSCSA) compliance, could necessitate significant ongoing product development and customer support investments."]
Competitors & peers
- Becton Dickinson (BD)
- Cardinal Health
- McKesson Corporation
- Intelligent Hospital Systems
- Fresenius Medical Care
Fundamentals: Finnhub, as of 2026-07-10. Filings: SEC EDGAR. Prices are delayed daily-close data.
Last updated 2026-07-09.
Informational only — NOT financial advice. All figures are delayed daily-close data from SEC EDGAR & Finnhub, shown with their as-of date.